According to industry sources, Sharps Technology completed a Private round of financing on August 25, 2025. Notable investors in this round include Pantera Capital, ParaFi Capital, Borderless Capital, CoinFund, Arrington Capital, Primitive Ventures, Hypersphere Ventures, FalconX, RockawayX, and Quantstamp.Sharps Technology is a Nasdaq-listed medical device company (ticker: STSS) specializing in the development and manufacturing of innovative safety syringes. The company's core mission is to reduce the risk of disease transmission from needlestick injuries through its technology, safeguarding healthcare workers, patients, and the public while improving the accuracy and efficiency of drug delivery.It is noteworthy that, according to the latest updates, Sharps Technology expanded its financing to USD 1 billion as of August 29, 2025, and launched a digital asset treasury strategy. Subsequently, on September 2, 2025, the company announced that its SOL holdings had exceeded 2 million tokens. These developments indicate that Sharps Technology is actively entering the digital asset sector by establishing a SOL treasury to diversify its business operations. The company’s completion of over USD 400 million in PIPE private placement financing will further support its strategic initiatives in medical technology innovation and digital asset management.